Jade Biosciences annual current ratio
2020
2021
2022
2023
2024
2025
Jade Biosciences Current Ratio Growth & History (JBIO)
Jade Biosciences's current ratio was 21.09 for fiscal 2025.
View full Jade Biosciences company overviewJade Biosciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 21.09 | 15.28 | +263.23% |
| 2024 | 2024-12-31 | 5.81 | −1.24 | −17.57% |
| 2023 | 2023-12-31 | 7.04 | −9.85 | −58.31% |
| 2022 | 2022-12-31 | 16.90 | −51.47 | −75.28% |
| 2021 | 2021-12-31 | 68.37 | 65.73 | +2493.69% |
| 2020 | 2020-12-31 | 2.64 | — | — |
Jade Biosciences quarterly current ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 14.93 | 4.61 | +44.73% |
| Q1 2026 | 2026-03-31 | 14.29 | −17.72 | −55.37% |
| Q4 2025 | 2025-12-31 | 21.09 | 15.28 | +263.23% |
| Q3 2025 | 2025-09-30 | 9.01 | 0.22 | +2.54% |
| Q2 2025 | 2025-06-30 | 10.31 | 3.81 | +58.49% |
| Q1 2025 | 2025-03-31 | 32.01 | 25.36 | +381.18% |
| Q4 2024 | 2024-12-31 | 5.81 | −1.24 | −17.57% |
| Q3 2024 | 2024-09-30 | 8.78 | −0.56 | −6.00% |
| Q2 2024 | 2024-06-30 | 6.51 | −4.97 | −43.30% |
| Q1 2024 | 2024-03-31 | 6.65 | −4.68 | −41.31% |
| Q4 2023 | 2023-12-31 | 7.04 | −9.85 | −58.31% |
| Q3 2023 | 2023-09-30 | 9.34 | −9.49 | −50.40% |
| Q2 2023 | 2023-06-30 | 11.48 | −29.38 | −71.91% |
| Q1 2023 | 2023-03-31 | 11.33 | −23.94 | −67.86% |
| Q4 2022 | 2022-12-31 | 16.90 | −51.47 | −75.28% |
| Q3 2022 | 2022-09-30 | 18.84 | −29.03 | −60.64% |
| Q2 2022 | 2022-06-30 | 40.85 | 26.71 | +188.83% |
| Q1 2022 | 2022-03-31 | 35.27 | — | — |
| Q4 2021 | 2021-12-31 | 68.37 | 65.73 | +2493.69% |
| Q3 2021 | 2021-09-30 | 47.87 | — | — |
| Q2 2021 | 2021-06-30 | 14.14 | — | — |
| Q4 2020 | 2020-12-31 | 2.64 | — | — |
Jade Biosciences current ratio trends
Over the last five fiscal years, Jade Biosciences's current ratio increased from 2.64 to 21.09, a change of 18.45. The latest reported quarter, Q2 2026, shows 14.93.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jade Biosciences source filings ↗